Germany and UK are also their 2 biggest markets in the EU
Revenue for the last 3 months = $962,000 AUD (for Bronchitol AND Aridol combined)
Be very careful with the pie in the sky forward looking figures presented by the company, if this drug was going to achieve any sort of substantial revenue it would be showing already.
Pulmozyme's revenue in its first qtr of sales in the US was 22.4 million USD (1994)
Germany and UK are also their 2 biggest markets in the EURevenue...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $27.46M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $36.31K | 1.599M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 793867 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 242619 | 3 |
View Market Depth
| Last trade - 15.46pm 25/06/2024 (20 minute delay) ? |
| SNT (ASX) Chart |